Great-West Lifeco Inc. (TSE:GWO – Free Report) – Investment analysts at National Bank Financial decreased their Q1 2025 earnings estimates for Great-West Lifeco in a research note issued to investors on Thursday, May 1st. National Bank Financial analyst G. Dechaine now forecasts that the company will earn $1.16 per share for the quarter, down from their previous forecast of $1.21. The consensus estimate for Great-West Lifeco’s current full-year earnings is $4.45 per share. National Bank Financial also issued estimates for Great-West Lifeco’s Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.18 EPS and Q4 2025 earnings at $1.20 EPS.
A number of other analysts have also recently weighed in on the stock. Cibc World Mkts upgraded shares of Great-West Lifeco from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 6th. Jefferies Financial Group lowered their price target on Great-West Lifeco from C$58.00 to C$57.00 in a report on Monday, April 21st. CIBC lowered their target price on Great-West Lifeco from C$60.00 to C$57.00 and set an “outperform” rating on the stock in a research note on Thursday, May 1st. BMO Capital Markets increased their price target on Great-West Lifeco from C$54.00 to C$59.00 and gave the stock a “market perform” rating in a report on Thursday, April 3rd. Finally, TD Securities boosted their price objective on shares of Great-West Lifeco from C$53.00 to C$62.00 and gave the company a “buy” rating in a research note on Thursday, April 3rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Great-West Lifeco presently has an average rating of “Hold” and a consensus target price of C$56.00.
Great-West Lifeco Trading Up 0.3 %
Shares of TSE GWO opened at C$52.52 on Monday. The stock has a market cap of C$48.90 billion, a P/E ratio of 12.02, a P/E/G ratio of 2.26 and a beta of 0.84. The stock has a 50 day moving average of C$53.16 and a two-hundred day moving average of C$50.07. Great-West Lifeco has a twelve month low of C$38.44 and a twelve month high of C$57.61.
Great-West Lifeco Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 31st were issued a dividend of $0.61 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $2.44 dividend on an annualized basis and a yield of 4.65%. This is an increase from Great-West Lifeco’s previous quarterly dividend of $0.56. Great-West Lifeco’s payout ratio is currently 50.79%.
Insiders Place Their Bets
In other news, Director Edmund Francis Murphy sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of C$52.31, for a total transaction of C$784,695.00. Also, Senior Officer Linda Kerrigan sold 8,500 shares of the company’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of C$51.64, for a total value of C$438,927.25. Over the last three months, insiders have sold 144,257 shares of company stock worth $7,640,646. 70.70% of the stock is owned by company insiders.
About Great-West Lifeco
Great-West Lifeco is one of the three big Canadian life insurance firms. With just under half of the firm’s profit and revenue in Canada, Great-West also operates in the U.S. and Europe. In Canada, Great-West provides both individual and group insurance. In the United States, Great-West operates Putnam Investments and defined-contribution recordkeeping firm Empower Retirement.
Further Reading
- Five stocks we like better than Great-West Lifeco
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- The Top-Ranked Insider Buys From April by Market Cap
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Great-West Lifeco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Great-West Lifeco and related companies with MarketBeat.com's FREE daily email newsletter.